INTRODUCTION
nomes. This novel phenotype of HSV-1 ICP8 mutants has been exploited to provide replication-defective mutant Productive infection by herpes simplex virus proceeds viruses for vaccine strains that can express a broad through a cascade of events in the order of immediate spectrum of viral proteins, including late proteins, in the early (IE) gene expression, early (E) gene expression, absence of viral DNA replication. The HSV-1 ICP8 mutant viral DNA replication, and late (L) gene expression. The d301 has been used to protect against lethal challenge expression of E proteins requires the IE protein ICP4 infection (Nguyen et al., 1992) and against establishment and, in some cases, the IE ICP27 protein. The expression of latent infection in a mouse corneal challenge model of viral late proteins requires IE proteins ICP4 and ICP27 Knipe, 1994, 1996) . The lack of viral DNA and viral DNA replication. Seven HSV-1 gene products, synthesis in cells infected with a vaccine virus would including the viral DNA polymerase (UL30), the polymerprovide greater safety in preventing viral DNA exposure ase accessory factor (UL42), the origin-binding protein to the host and the cellular mutagenic events that have (UL9), the single-stranded DNA-binding protein (UL29 or been associated with viral DNA replication, including cel-ICP8), and the helicase-primase complex (UL5, UL8, and lular DNA amplification (Heilbronn and Zur Hausen, 1989) UL52) are required for viral DNA replication (Challberg, and chromosomal aberrations (Chenet-Monte et al., 1986; Knipe, 1989; Weller, 1991) . The ICP8 protein also 1986). plays a role in regulating viral gene expression in that Herpes simplex virus 2 (HSV-2) is responsible for most ICP8 ts mutants show overexpression of viral gene prodcases of genital herpes disease. Pregnant women with ucts at the nonpermissive temperature (Godowski and genital herpes are at risk of transmitting the virus to Knipe, 1985 Knipe, , 1986 , and a dominant mutant form of ICP8 their newborns at parturition, which may result in severe, can inhibit late gene transcription (Chen and Knipe, 1996;  potentially fatal neurologic or disseminated disease in Gao and Knipe, 1991) . A notable phenotype of viral muthe newborn. Several vaccines against HSV-2, including tants bearing ts and deletion mutations in the ICP8 gene subunit glycoprotein preparations (Meignier et al., 1987 ; is the expression of substantial amounts of late viral Mertz et al., 1990; Stanberry et al., 1987) , have been proteins in the absence of viral DNA replication. Theretested for their ability to prevent genital disease in animal fore, HSV-1 ICP8 plays a role in suppressing transcription models as well as in clinical trials. In addition, viral vecof viral late genes from input or parental viral DNA getors such as human adenovirus expressing HSV-2 glycoprotein B (gB) (McDermott et al., 1989) and vaccinia virus expressing HSV-2 glycoproteins D, E, G, and part of I which were prepared as described by Stanberry (1982) . In experiments in which inactivated virus was used to have been tested in several animal models including guinea pigs and owl monkeys (Meignier et al., 1988a, immunize animals, virus stocks were inactivated with bpropiolactone, resulting in a 5-log reduction in virus titer. 1988b, 1990) . This vaccine has also been tested in clinical trials, the results of which have been reviewed rePlasmids cently (Stanberry, 1996) . In addition, an HSV-2 gH gene deletion mutant virus that undergoes a single round of Plasmid pICP8-lacZ was constructed by digesting replication in infected cells has been tested in guinea HSV-1 HD-2 DNA with BamHI and cloning the largest pigs for its ability to protect against an HSV-2 challenge fragment, approximately 12.2 kbp in size, into the BamHI (Boursnell et al., 1997) . More recently, nucleic acid vacsite of plasmid pNEB193 (New England Biolabs, Beverly, cines expressing HSV-2 gD have been evaluated in mice MA). This HD-2 BamHI fragment extends from upstream or guinea pig models of genital herpes (Bourne et al., of the ICP8 promoter (BamHI V/R junction of HSV-1; bp 1996; Ghiasi et al., 1995; Kriesel et al., 1996) . 62,653 from the sequence of McGeoch et al. (1988) ) to HSV-2, although less well studied than HSV-1, is highly downstream of the gB gene (BamHI G/E junction; bp homologous to HSV-1 and shows many common gene 52,588 (McGeoch et al., 1988) ). Following transformation regulatory patterns. The HSV-2 ICP8 is also required for into bacterial cells, white colonies selected on medium viral DNA synthesis (Spang et al., 1983) and can substicontaining the chromogenic substrate X-Gal were tute for HSV-1 ICP8 (Conley et al., 1981; Morse et al., screened for the presence of the insert. The identity of 1978). However, nothing is known about the effects of desired clones was confirmed by restriction endonucle-HSV-2 ICP8 on viral gene expression. To determine if ase analysis. Plasmid pEH60 (Spang et al., 1983) , which HSV-2 ICP8 exerted regulatory effects similar to those of contains an EcoRI-HindIII DNA fragment from HSV-2 the HSV-1 protein and to determine if an HSV-2 ICP8 strain 186 syn / -1 from approximately 0.31-0.40 map mutant virus could provide a safe, live virus vaccine units, that was cloned into pBR322 was used to rescue against genital herpes, we have engineered an HSV-2 the HSV-2 ICP8 0 mutant, 5BlacZ, constructed in this ICP8 mutant virus, characterized the effect of HSV-2 ICP8 study. All restriction enzymes were obtained from New on viral gene expression, and conducted initial tests of England Biolabs. this mutant virus for its ability to protect guinea pigs against vaginal HSV-2 challenge. We selected the guinea Marker transfer using cotransfection pig model because it has been used to evaluate several vaccine candidates that are currently in clinical trials Viral recombinants were isolated by homologous recombination in cells cotransfected with infectious HSVand because the model mimics genital HSV infection in humans using a natural route of inoculation (intravaginal) 2 DNA and cloned segments of viral DNA as described previously (Spang et al., 1983) . The method used was a to produce a self-limited primary infection which results in establishment of latency and subsequent spontaneous modification of the calcium phosphate coprecipitation method (Graham recurrent infections (Stanberry, 1991) .
and Van der Eb, 1973) . Infectious HSV-2 viral DNA was purified by sodium iodide density gradient centrifugation MATERIALS AND METHODS (Walboomers and ter Schegget, 1976) . Cloned viral DNA Cells and viruses sequences for cotransfection were cleaved from recombinant plasmids, isolated by gel electrophoresis, purified Vero (ATCC, Rockville, MD) and S2 cells which contain the HSV-1 ICP8 gene were grown and maintained as by phenol-chloroform extraction and ethanol precipitation, and resuspended in TE buffer. Alternatively, recomdescribed previously (Gao and Knipe, 1989) . The HSV-1 ICP8 0 mutant virus strain HD-2, which contains the lacZ binant plasmids were linearized outside of the HSV sequences and purified. The cloned sequences were cocoding sequences fused to the ICP8 ORF, has been described previously (Gao and Knipe, 1989) . The wild-type transfected with 1 mg of infectious viral DNA at plasmid:viral DNA molar ratios ranging from 5:1 to 30:1 HSV-2 strain 186 syn / -1 virus, used as the parental wildtype (wt) HSV-2 strain, was originally isolated as a noninto subconfluent S2 cell monolayers in 25-cm 2 flasks (Corning Inc., Corning, NY). Each flask was transfected syncytial plaque (Spang et al., 1983) from HSV-2 strain 186 (Rawls et al., 1968) stock kindly provided by P. Schafwith a total of 16 mg of DNA with salmon sperm DNA serving as carrier. After viral CPE was apparent, infected fer. The HSV-2 strain MS (Stanberry et al., 1982) was used as the vaginal challenge virus in immunized and cell lysates were prepared by the addition of 0.5 vol of sterile reconstituted milk (nonfat powdered milk; Carnacontrol animals. All ICP8 0 mutant viruses were grown on the complementing S2 cell line. The wild-type HSV-2 tion Co., Los Angeles, CA), three cycles of freeze-thawing, and sonication. The transfected cell lysate containing strains 186 syn / -1 and MS were grown on Vero cells and primary rabbit kidney (PRK) cells, respectively. Virus the progeny virus was plated in 10-fold dilutions on confluent S2 or Vero cell monolayers in 6-well trays (Cornstocks were prepared and stored as described by Morrison and , except for challenge virus stocks ing). The infected monolayers were overlaid with 199-1% CS medium (199 medium containing 1% calf serum) were resuspended in a 0.5% (w/v) solution of trypan blue in phosphate-buffered saline and counted in a hemocyplus 0.1% human Ig (Massachusetts Public Health Biologic Labs, Boston, MA) and incubated at 37Њ. harvested at various times postinoculation. Cell lysates they were shaken off, transferred to 50-ml polypropylene were subjected to SDS-PAGE in 9.25% gels. Following centrifuge tubes (Corning), and collected by centrifugaelectrophoresis, gels were fixed, stained with Coomassie tion at 300 g, 4Њ in an IEC centrifuge (Model CRU-5000, blue, dried, and exposed to Kodak SB-5 film for autoradiNeedham Heights, MA). The cells were gently lysed in ography. To quantify the levels of viral proteins expressed buffer (100 mM Tris-Cl, pH 8.0; 10 mM EDTA, 1% SDS), in infected cells, the autoradiograms were scanned using and the lysate was digested with Proteinase K (200 mg/ an LKB Bromma Ultrascan XL Laser densitometer, and ml). Viral DNA was isolated using sodium iodide gradipeak areas representing specific viral protein bands ents, dialyzed against TE buffer, quantitated by UV specwere determined. trophotometry, enzymatically restricted with EcoRI and KpnI, SalI, or XhoI, resolved by electrophoresis in 0.7% Immunoblots agarose gels, and transferred to nylon membranes (Nytran; Schleicher and Schuell, Keene, NH) for Southern
The levels of expression of specific viral glycoproteins hybridization. The membranes were probed with linearwere determined by immunoblot assay. Infected cell lyized, 32 P-labeled pICP8-lacZ plasmid DNA. Labeling with sates were resolved by electrophoresis using a mini pro-[a 32 P]dCTP (New England Nuclear, Boston, MA) was pertein gel apparatus (Bio-Rad, Richmond, CA), electroblotformed using a random-primer labeling kit (Boehringer ted onto nitrocellulose membranes, and probed for viral Mannheim, Indianapolis, IN).
glycoproteins gB and gD. Rabbit polyclonal sera R1161 (provided by Dr. R. Courtney) and R-45 (provided by Dr. DNA replication G. Cohen and Dr. R. Eisenberg) were used as primary antibodies to detect glycoproteins gB and gD, respecTo examine viral DNA replication, Vero cells were intively. Goat anti-rabbit alkaline phosphatase-conjugated fected with wild-type virus or 5BlacZ at an m.o.i. of 20 or secondary antibody (Promega, Madison, WI) was used to were mock-infected. Cells were overlaid with 199-1% detect the immune complexes. The enzymatic substrates CS medium and incubated at 37Њ. DNA was labeled from nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indo-3 to 7 hr postinoculation by changing the overlay medium lylphosphate (BCIP) were used in the reaction to detect to 199-1% CS containing 25 mCi/ml [ 3 H]thymidine (New alkaline phosphatase activity as recommended by the England Nuclear). Cells were harvested at 7 hr postinocsupplier (Promega). ulation, and total DNA was isolated as described by Challberg (1986) . Equivalent amounts of labeled DNA Animals were digested with BamHI and resolved by electrophoresis in 0.5% agarose gels. The gel was fluorographed Female Hartley guinea pigs were obtained from (Entensify, New England Nuclear), dried, and exposed to Charles River Breeding Laboratories (Wilmington, MA) film (Kodak XAR) at 080Њ for 3 days.
and housed under AAALAC-approved conditions. All procedures and protocols were approved by Children's HosCell viability pital Research Foundation Animal Care and Use Committee (Cincinnati, OH). The viability of infected cells was assayed by trypan blue exclusion (Fuller et al., 1995) . Briefly, confluent Vero
Immunization studies cell monolayers in T25 flasks were infected with wildtype virus or 5BlacZ at an m.o.i. of 5 or mock-infected Female guinea pigs were randomized into three groups of 12 animals each and were immunized with 0.5 and harvested at 24, 48, or 72 hr postinoculation. Cells ml of a suspension containing 10 7 PFU of 5BlacZ by subcutaneous injection on the back or into the two rear footpads or were left unimmunized. In other experiments, animals were immunized with 5BlacZ either vaginally with live virus or in the rear footpads with live or inactivated virus. Viral challenge was performed on Day 33 postimmunization. The animals were inoculated with virus by rupturing the vaginal closure membrane with a moistened calcium alginate-tipped swab (Calgiswab 3, Spectrum Labs, Los Angeles, CA) and instilling 0.1 ml of a virus suspension containing 5 1 10 5 PFU of HSV-2 strain MS into the vaginal vault using a plastic catheter (Abbocath, Abbott Labs, North Chicago, IL). To maximize the number of animals infected, the inoculation procedure was repeated 30 min later. Vaginal swab samples were collected on Days 1, 2, 3, 5, 7, and 10 postinocula- Guinea pigs were evaluated daily and the severity of The vector is indicated by the light stippled area. The ICP8 gene is primary genital skin disease was quantified using a leindicated by the black arrow. The lacZ coding sequences are indicated sion score scale described previously (Stanberry et al., 10 postinoculation. Following recovery from primary infection, animals were examined daily from Days 15 to 42 postinoculation for evidence of spontaneous recurrent plaques appeared blue. Several independently isolated herpetic disease (Stanberry et al., 1985a) . blue plaques were screened for the presence of the ICP8 mutation by the ability to grow on the S2 complementing RESULTS cell line and the failure to grow on Vero cells. Two such isolates, 5BlacZ and 20BlacZ, were plaque-purified thrice Construction of an HSV-2 ICP8 gene mutant and their genomes were checked by Southern analysis. To introduce a mutation into the HSV-2 ICP8 gene, we chose to replace the HSV-2 ICP8 gene with an ICP8-Analysis of the mutant viral genomes lacZ gene fusion that we had previously engineered in the HSV-1 HD-2 viral strain (Gao and Knipe, 1989) . The
The growth of 5BlacZ on S2 cells, which express ICP8 upon HSV infection and complement the growth of ICP8 feasibility of this approach was suggested by the extensive homology between the HSV-1 and HSV-2 genomes mutant viruses, provided the initial evidence that the mutation in 5BlacZ was in the ICP8 gene. To confirm that and the previous ease of isolation of intertypic recombinants in general (Marsden et al., 1978; Morse et al., 1978) the ICP8 gene was mutated in 5BlacZ, we performed Southern blot analysis on viral DNA from 5BlacZ, its siband around the ICP8 gene in particular (Conley et al., 1981) . To this end, we cloned a BamHI DNA fragment ling 20BlacZ, the HSV-1 HD-2 strain, and the parental HSV-2 186 wt strain. Viral DNA was digested with EcoRI encompassing the ICP8-lacZ gene fusion from HD-2 virus DNA into plasmid vector pNEB193 to generate plasand KpnI, resolved by gel electrophoresis, transferred to nylon membranes, and probed with a 32 P-labeled BamHI mid pICP8-lacZ (Fig. 1) . Because this BamHI fragment contains other viral genes including the gB gene of HSV-DNA fragment from HD-2 shown in the second line of Fig. 2D . The probe hybridized with two fragments of 6.4 1, a 6.4-kbp KpnI subfragment containing the ICP8-lacZ gene fusion but excluding the gB gene was isolated and and 7.8 kbp (Fig. 3 , lane 1) of HSV-2 wt DNA, which map as shown in Fig. 2D . In contrast, the probe hybridized used to construct the HSV-2 ICP8 mutant virus (Fig. 1) . This fragment, which extends from 233 bp downstream strongly with four fragments of 1.9, 3.6, 2.8, and 4.7 kbp of HD-2 DNA (Fig. 3, lane 4) , which map as shown in of the ICP8 ATG initiation codon to approximately 1.3 kbp upstream of the gB gene promoter, was cotransfected Fig. 2D . With 5BlacZ and 20BlacZ DNA, the probe hybridized to new fragments of 5.5 and 2.9 kbp as well as to with HSV-2 186 syn / -1 viral DNA into S2 cells. From the progeny viruses, we isolated viruses that formed blue a 7.8-kbp fragment similar to that of HSV-2. The new fragments in 5BlacZ and 20BlacZ were consistent with plaques under an X-Gal overlay and contained the ICP8-lacZ gene fusion inserted into the ICP8 gene (Fig. 2) . In a recombinational event inserting the ICP8-lacZ gene fusion into the 6.4-kbp fragment of HSV-2 or within the the initial screen for viruses that formed blue plaques under the X-Gal overlay, approximately 1 in every 10 3 ICP8 gene (Fig. 2D) . No other bands were observed with 5BlacZ or 20BlacZ (Fig. 3, lanes 2 and 3) , providing evithe lower limit for the titer of 5BlacZ on Vero cells ( Knipe, 1989; Orberg and Schaffer, 1987) .
infected with either wt HSV-2 or 5BlacZ or mock-infected The HSV-2 ICP8 mutant isolated in this study, 5BlacZ, and enzymatically restricted and resolved in agarose was also examined for its phenotypic properties. gels (Fig. 4) . From cells infected with wt virus, a series Growth properties. The 5BlacZ mutant virus formed of viral DNA bands was labeled (Fig. 4, lane 1) , consistent plaques and grew to titers comparable to those of wt with viral DNA synthesis, while a smear of bands was virus on S2 cells but did not form plaques on Vero cells labeled in mock-infected cells due to cellular DNA repli- (Table 1) . At low dilutions, a general cytopathic effect cation (Fig. 4, lane 3) . In contrast, no viral DNA bands was observed on Vero cells, preventing detection of any were labeled in cells infected with 5BlacZ (Fig. 4 , lane 2), indicating that no viral DNA synthesis occurred in replication-competent virus at these dilutions. Therefore, gene, we used marker rescue to restore a wild-type ICP8 these cells. Furthermore, cell DNA labeling was greatly reduced in these mutant virus-infected cells (Fig. 4, lane gene into the 5BlacZ genome. The ICP8 mutation in 5BlacZ was rescued with plasmid pEH60, which contains 2). Therefore, HSV-2 ICP8 is required for viral DNA synthesis but not for the bulk of the shut-off of host DNA the ICP8 gene of the parental HSV-2 186 syn / -1 strain. Mutant virus was rescued at a frequency of between synthesis in infected cells. Nevertheless, we cannot rule out the possibility that ICP8 is required for a small part 0.04 and 2%. One of the rescuants, 5BR, was chosen for characterization. The 5BR strain grew equally well on of the shut-off of host DNA synthesis.
Gene expression. Initial comparisons of protein exVero and S2 cells (Table 1) . Southern blot analysis of the rescued virus and wt HSV-2 virus using the HSV-1 ICP8 pression by 5BlacZ and wild-type virus showed some differences in levels and patterns of protein expression plasmid p8B-S (Gao and Knipe, 1989) as probe revealed identical hybridization patterns for the two viruses (re-(results not shown). To prove that the protein expression phenotype of 5BlacZ was due to the mutation in the ICP8 sults not shown). control cells (0PAA). Thus, although the mutant virus did not replicate its genome, it expressed gB, an important target for anti-HSV immunity, at levels nearly equivalent to those of the rescued virus.
Levels of accumulation of glycoproteins gB and gD. The above results using analysis of labeled protein equivalent amounts of lysates revealed that cells infected with 5BlacZ accumulated gB (Fig. 6 , lanes 5-8) and gD (Fig. 6, lanes 1-4) at levels only slightly lower than those We then examined the patterns of protein synthesis in in cells infected with wt virus. Therefore, 5BlacZ exVero cells infected with the mutant 5BlacZ, the rescuant pressed significant levels of authentic gB and gD al-5BR, or wild-type virus in the presence and in the abthough it did not replicate viral DNA. sence of PAA, a specific inhibitor of viral DNA synthesis. At 5 or 9 hr postinoculation, we labeled the cultures with [
S]methionine and [
35 S]cysteine for 30 min. The cells were harvested, and infected cell-lysates were prepared and resolved by SDS-PAGE (Fig. 5) . Examination of autoradiograms revealed that major proteins of all kinetic classes were expressed by 5BlacZ at levels similar to or slightly less than those expressed by the wild-type parental virus (Fig. 5) , including g genes such as ICP5, gB, and ICP15. Densitometric measurements of the band intensities of the late gene products at 9 hr postinoculation revealed that 5BlacZ expressed late proteins at 25-79% of the levels of the rescued virus in cells infected in the absence of PAA (Table 2) . When PAA was added to all cultures to inhibit viral DNA synthesis in both mutant and rescued-mutant infected cultures, 5BlacZ expressed late proteins at levels similar (gB) to or 2-to 2.5-fold greater Proteins from 5BlacZ-(lanes 1, 2, 5, and 6) or HSV-2 wt-(lanes 3, 4, 7, and 8) infected cell lysates were electroblotted from SDS-polyacryl-(ICP5, ICP15, ICP25) than the levels expressed by the amide gels onto nitrocellulose membranes and probed with either antirescued virus (Table 2) pressed gB at 67% of the level of the rescued virus in infectious progeny in those cells, we investigated its ability to elicit protective immunity against HSV-2 genital disease in a guinea pig model. Animals were immunized with 5BlacZ by one of three routes: subcutaneous injection in the back, subcutaneous injection in the rear footpad, or intravaginal immunization. Immunizations were performed with either live or inactivated virus stocks. Following immunization, all animals were challenged with wt HSV-2. Two challenge stocks of the same HSV-2 MS strain were used: one a high-virulence stock used mainly to study primary disease and the other a lowvirulence stock used mainly to study recurrent disease.
Effects of immunization on primary infection and disease. Three groups of 12 female Hartley guinea pigs were immunized with a single dose of 10 7 PFU of 5BlacZ virus administered subcutaneously in the footpads or in the back, or left untreated. At Day 33 postimmunization, the animals were challenged intravaginally with a highvirulence stock of HSV-2 strain MS to achieve an efficient, (Stanberry, 1982) with wt HSV-2 or 5BlacZ at an m.o.i. of 5 or mock-infected and harvested and evaluated daily for signs of disease (Table 3 ). The at 1, 2, or 3 days postinoculation. Loss of cell viability was determined amount of virus shed in the genital tract of all animals by trypan blue dye uptake and expressed as a percentage of the total was also determined from vaginal swabs taken at various cell count. times postinoculation (Fig. 8) . A single immunization with 5BlacZ afforded guinea pigs significant protection from Viability of cells infected with mutant virus genital herpes. In contrast to the control group in which A potential concern about the use of a replication-11 of 12 animals exhibited lesions, only 3 of 12 animals defective mutant virus as a vaccine is that the infected immunized in the footpad developed the cutaneous lecell might survive and the mutant virus could establish sions characteristic of primary genital herpes, and disa persistent infection in the host. We therefore examined ease in these animals was very mild. In addition, 6 of the fate of cells infected with the mutant virus. Vero cells were infected with either wt HSV-2 or 5BlacZ and harvested at 1, 2, or 3 days postinoculation. Loss of cell by Days 1 and 2 and a 10-fold increase by Day 3, at which time 100% of infected cells were nonviable. Over a Number of animals with clinical disease/number of animals in the same 3-day period, the percentage of nonviable cells which virus could be isolated from the genital tract.
among the uninfected controls remained at approxib Mean { SE. Severity measured as the area under the lesion score mately 10%. Thus, it is clear that, despite the defect in curve calculated using only symptomatic animals.
its ability to replicate in Vero cells, 5BlacZ is still able to c Number of animals with recurrent disease/number of infected animals which could be assessed for recurrences from Days 15 to 42 kill cells at a level comparable to wild-type virus. Like postinoculation.
wt virus infection (Leopardi and Roizman, 1996) , cells d P õ 0.07 compared to untreated controls (Fisher's two-tail exact infected with 5BlacZ appeared to die from necrosis in test).
that cellular DNA fragmentation was not observed (ree P õ 0.01 compared to untreated controls (Bonferroni correction sults not shown).
ANOVA).
f P õ 0.003 compared to untreated controls (Fisher's two-tail exact
Immunization studies with 5BlacZ test).
Given the ability of 5BlacZ to express nearly wild-type g P õ 0.05 compared to subcutaneous animals (Bonferroni correction ANOVA).
levels of gB and gD in normal cells but not produce in the footpad or with an equivalent amount of virus that had been inactivated by 5 logs with b-propiolactone. Immunization with 5BlacZ provided significant protection 12 subcutaneously immunized animals developed skin against disease caused by primary infection as mealesions, and the severity of disease was significantly resured by the number and severity of lesions compared duced compared to unimmunized controls. Thus, protecto the untreated controls (Table 4) . None of the 15 anition from disease by subcutaneous immunization was mals that received an inoculation of live virus via the less than that achieved with footpad immunization. Alfootpad developed primary genital skin disease comthough immunization with 5BlacZ protected animals from pared to 4 of 10 animals that received inactivated virus primary genital herpes, 12 of 23 immunized animals deby the same route that did develop primary disease. Most veloped recurrent genital herpes, indicating that a single importantly, the number of animals showing recurrent immunization elicited only partial protection from estabinfections was significantly reduced by footpad immunilishment of latent infection with this dose of high-viruzation (Table 5) , and the frequency of recurrences was lence challenge virus.
To examine the effects of immunization on viral shed- ensure an adequate number of animals for evaluation of reduced significantly by footpad or vaginal immunization normal inhibition of host cell DNA synthesis; therefore, ICP8 is not required for this effect of the virus. HSV ICP8 (Table 5) . For all parameters of challenge virus infection, live virus provided better protection than inactivated viis required for the redistribution of sites of host cell DNA synthesis in the nuclei of infected cells (de Bruyn Kops rus. The protection against recurrent disease afforded to animals immunized with 5BlacZ was significant comand Knipe, 1988) . Thus, the redistribution of host cell DNA synthesis sites and the inhibition of host cell DNA pared to untreated controls (Table 5) . Fewer of the immunized animals developed recurrent lesions, and among synthesis appear to be separate effects of HSV infection on the host cell. Consistent with the host cell shut-off those that did, a significant reduction in the frequency of recurrence during the period of evaluation was observed properties of the 5BlacZ mutant, cells infected with this mutant showed CPE similar to that of cells infected with compared to control animals. Thus immunization with 5BlacZ provided significant protection against primary wt virus as well as similar kinetics of loss of viability. This indicates that although 5BlacZ does not replicate and recurrent infection, and live virus provided better protection than killed virus.
its DNA, it completes enough of the replicative cycle to cause cell death. It is unlikely that any significant amount of 5BlacZ will spread to sensory neurons to establish a DISCUSSION latent infection (Katz et al., 1990) . The implication of these considerations is that, in host organisms immunized with We have constructed and characterized a replicationdefective HSV-2 mutant and shown it to protect against 5BlacZ, infected cells will not survive and 5BlacZ is not likely to persist in the host after inoculation of this virus genital herpes in a guinea pig model of HSV-2 disease. The virus has a mutation in an essential early gene, ICP8, for immunization. Experiments are in progress to measure the ability of HSV-2 replication-defective mutants to and grows only on cells that express functional ICP8. In normal cells infected with this HSV-2 ICP8 mutant virus, establish latent infection. The immunization studies in this report were designed expression of IE, E, and at least some L genes occurs although there is no viral DNA replication. In the absence to provide an initial test of the feasibility of using the 5BlacZ mutant virus to elicit protective immunity against of viral DNA replication, 5BlacZ can express significant levels of the late proteins ICP5, ICP15, and ICP25 and genital herpes infection in the guinea pig model. Immunization with one dose of 5BlacZ did reduce the incidence the glycoproteins gB and gD. Previous studies have shown that HSV-1 ICP8 not only serves as an essential and severity of genital disease and the shedding of virus from primary infection of the genital tract. Immunization component of the viral DNA replication apparatus but also is involved in the regulation of viral gene expression.
did not prevent infection by the challenge virus in that virus shedding was the same for immunized and unimSpecifically, HSV-1 ICP8 plays a role in repressing late gene expression from parental genomes while stimulatmunized animals on Day 1. Thus, immunization with the mutant virus reduced disease and virus spread, and furing late gene expression from progeny genomes (Chen and Knipe, 1996; Gao and Knipe, 1991; Godowski and ther studies are needed to optimize the dose and frequency to further increase the protection against primary Knipe, 1985) . The regulatory effects exerted by ICP8 are independent of its role in DNA synthesis; therefore, ICP8 infection. A second experiment to measure protection against recurrent infection involved two immunizations mutants showed altered gene expression compared to wild-type virus in the presence of a viral DNA synthesis with 5BlacZ and challenge with a less virulent stock of HSV-2. This showed better protection against primary inhibitor. The ICP8 mutation in HSV-2 resulted in a similar phenotype to that observed for HSV-1 ICP8 mutant vidisease, probably due to the increased number of immunizations. These immunized animals showed decreased ruses. The HSV-2 5BlacZ mutant virus was unable to replicate its DNA and demonstrated altered gene expresrecurrent infections compared to the control animals, indicating that immune effector mechanisms are acting to sion compared to wild-type virus or the rescued strain 5BR. Based on these observations, it appears that ICP8 decrease establishment of latent infection or reactivation or both. Studies of immune protection against establishexerts similar effects on gene expression in both HSV-1 and HSV-2. The similarity in the functions of HSV-1 and ment of latent infection by HSV-1 in murine trigeminal ganglia have shown that CD4 / T cells play a major role HSV-2 ICP8 is reinforced by the ability of the HSV-1 ICP8 expressed by the S2 cell line to complement the growth in protection from latent infection (Morrison and Knipe, manuscript in preparation), but little is known about imof the HSV-2 mutant virus. Growth of 5BlacZ in S2 cells has the potential for rescue of the mutant virus by recommune mechanisms protecting against latent infection by HSV-2. Further studies are needed to define the stage bination with the resident HSV-1 ICP8 gene in the S2 cell line. Nevertheless, although the HSV-1 ICP8 gene can of HSV-2 infection or reactivation blocked by the host immune response and the necessary components of that functionally complement the defect in HSV-2 virus, the HSV-2 genome and the HSV-1 gene do not readily recomresponse.
One of the primary concerns about any live-virus vacbine with each other as evidenced by the absence of detectable wild-type recombinants (õ3 1 10 07 ). cine must be safety. Live attenuated HSV-2 strains have given some viral disease in animal models (McDermott The ICP8 mutant studied in this work showed nearly
